REFERENCES
1. Müller J, Szűcs-Farkas D, Szegedi I, Csóka M, Garami M, Tiszlavicz
LG, et al. Clinical Course of COVID-19 Disease in Children Treated With
Neoplastic Diseases in Hungary. Pathol Oncol Res. 2022;28:1610261.
2. Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et
al. Global characteristics and outcomes of SARS-CoV-2 infection in
children and adolescents with cancer (GRCCC): a cohort study. Lancet
Oncol. 2021 Oct;22(10):1416–26.
3. WHO Coronavirus (COVID-19) Dashboard [Internet]. [cited 2023
Apr 23]. Available from: https://covid19.who.int
4. Kahn AR, Schwalm CM, Wolfson JA, Levine JM, Johnston EE. COVID-19 in
Children with Cancer. Curr Oncol Rep. 2022 Mar 1;24(3):295–302.
5. Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani
MA, et al. COVID-19 and stem cell transplantation; results from an EBMT
and GETH multicenter prospective survey. Leukemia. 2021
Oct;35(10):2885–94.
6. Bhatt NS, Sharma A, St Martin A, Abid MB, Brown VI, Diaz Perez MA, et
al. Clinical Characteristics and Outcomes of COVID-19 in Pediatric and
Early Adolescent and Young Adult Hematopoietic Stem Cell Transplant
Recipients: A Cohort Study. Transplant Cell Ther. 2022
Oct;28(10):696.e1-696.e7.
7. Schlage S, Lehrnbecher T, Berner R, Simon A, Toepfner N. SARS-CoV-2
in pediatric cancer: a systematic review. Eur J Pediatr. 2022 Apr
1;181(4):1413–27.
8. Averbuch D, de la Camara R, Tridello G, Knelange NS, Bykova TA,
Ifversen M, et al. Risk factors for a severe disease course in children
with SARS-COV-2 infection following hematopoietic cell transplantation
in the pre-Omicron period: a prospective multinational Infectious
Disease Working Party from the European Society for Blood and Marrow
Transplantation group (EBMT) and the Spanish Group of Hematopoietic Stem
Cell Transplantation (GETH) study. Bone Marrow Transplant. 2023
May;58(5):558–66.
9. El-Qushayri AE, Benmelouka AY, Dahy A, Hashan MR. COVID-19 outcomes
in paediatric cancer: A large scale pooled meta-analysis of 984 cancer
patients. Reviews in Medical Virology. 2022;32(5):e2344.
10. SEHOP 2021: Inicio [Internet]. [cited 2023 Sep 26].
Available from:
https://www.geyseco.es/sehop2021/www.geyseco.es/sehop2021
11. XIV Congreso Nacional de la Sociedad Española de Hematología y
Oncología Pediátricas: Inicio [Internet]. [cited 2023 Sep 26].
Available from:
https://www.geyseco.es/sehop2022/www.geyseco.es/sehop2022
12. Latella A, Gómez S, Palladino M, Navia M, Mangano A, Borgnia D, et
al. COVID-19 in Pediatric Cancer Patients and Hematopoietic Stem Cell
Transplant Recipients in a Tertiary Care Hospital in Argentina. J
Pediatr Hematol Oncol. 2023 Aug 1;45(6):e671–7.
13. Faura A, Rives S, Lassaletta Á, Sebastián E, Madero L, Huerta J, et
al. Initial report on Spanish pediatric oncologic, hematologic, and post
stem cell transplantation patients during SARS-CoV-2 pandemic. Pediatr
Blood Cancer. 2020 Sep;67(9):e28557.
14. Ilinca AP, Dakhallah N, Souza AM, Leclerc M, Mezziani S, Brossard J,
et al. Update: Clinical characteristics and outcomes of SARS‐CoV‐2
infection in pediatric oncology patients in the province of Quebec.
Pediatr Blood Cancer. 2022 Aug 21;e29936.
15. Pagano L, Salmanton-García J, Marchesi F, Blennow O, Gomes da Silva
M, Glenthøj A, et al. Breakthrough COVID-19 in vaccinated patients with
hematologic malignancies: results from the EPICOVIDEHA survey. Blood.
2022 Dec 29;140(26):2773–87.
16. Salmanton-García J, Marchesi F, Glenthøj A, Bilgin YM, van Praet J,
Dávila-Valls J, et al. Improved Clinical Outcome of COVID-19 in
Hematologic Malignancy Patients Receiving a Fourth Dose of
Anti-SARS-CoV-2 Vaccine: An EPICOVIDEHA Report. Hemasphere. 2022
Nov;6(11):e789.
17. Parambil BC, Moulik NR, Dhamne C, Dhariwal N, Narula G, Vora T, et
al. COVID-19 in Children with Cancer and Continuation of Cancer-Directed
Therapy During the Infection. Indian J Pediatr. 2022 May
1;89(5):445–51.
18. Millen GC, Arnold R, Cazier JB, Curley H, Feltbower R, Gamble A, et
al. COVID-19 in children with haematological malignancies. Arch Dis
Child. 2022 Feb;107(2):186–8.
19. Zama D, Baccelli F, Colombini A, Contino A, Calore E, Petris MG, et
al. Favorable outcome of SARS-CoV-2 infection in pediatric hematology
oncology patients during the second and third pandemic waves in Italy: a
multicenter analysis from the Infectious Diseases Working Group of the
Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP). Ann
Hematol. 2022 Aug 1;101(8):1843–51.
TABLE 1. - Characteristics of SARS-CoV-2 infection in children
without comorbidities and children with cancer. Descriptive analysis
(mean (SD); N (%)) and p values obtained by Chi-Squared, Fisher,
Mann-Whitney test or logistic regression. Only significant variables are
shown.